Detalhe da pesquisa
1.
Cardiac atrial pathology in Duchenne muscular dystrophy.
Muscle Nerve
; 69(5): 572-579, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38426616
2.
Repeated intravenous cardiosphere-derived cell therapy in late-stage Duchenne muscular dystrophy (HOPE-2): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet
; 399(10329): 1049-1058, 2022 03 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35279258
3.
An evaluation of clinical presentation and genetic testing approaches for patients with neuromuscular disorders.
Am J Med Genet A
; 191(11): 2679-2692, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37503964
4.
A longitudinal study of creatine kinase and creatinine levels in Duchenne muscular dystrophy.
Muscle Nerve
; 67(2): 138-145, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36444146
5.
Obesity and loss of ambulation are associated with lower extremity oedema in Duchenne muscular dystrophy.
Cardiol Young
; 33(4): 597-602, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35549789
6.
An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids.
Genet Med
; 23(4): 740-750, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33239752
7.
The effect of oral bisphosphonate therapy on vertebral morphometry and fractures in patients with Duchenne muscular dystrophy and glucocorticoid-induced osteoporosis.
Muscle Nerve
; 64(6): 710-716, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34506040
8.
Age-related changes in appendicular lean mass in males with Duchenne muscular dystrophy: A retrospective review.
Muscle Nerve
; 63(2): 231-238, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33104257
9.
Emergency Planning as Part of Healthcare Transition Preparation for Patients with Duchenne Muscular Dystrophy.
J Pediatr Nurs
; 61: 298-304, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34450470
10.
Neurodevelopmental, behavioral, and emotional symptoms common in Duchenne muscular dystrophy.
Muscle Nerve
; 61(4): 466-474, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31909820
11.
Neurodevelopmental, behavioral, and emotional symptoms in Becker muscular dystrophy.
Muscle Nerve
; 61(2): 156-162, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31650559
12.
Comparison of Pulmonary Function Decline in Steroid-Treated and Steroid-Naïve Patients with Duchenne Muscular Dystrophy.
J Pediatr
; 210: 194-200.e2, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30955791
13.
Long-Term Outcome of Interdisciplinary Management of Patients with Duchenne Muscular Dystrophy Receiving Daily Glucocorticoid Treatment.
J Pediatr
; 182: 296-303.e1, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28043681
14.
Correction to: An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids.
Genet Med
; 23(12): 2467, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34667295
15.
Treatment of SCN4A-induced myotonic crisis.
Muscle Nerve
; 63(6): E59-E61, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33745142
16.
Theabrownin from Fu Brick tea ameliorates high-fat induced insulin resistance, hepatic steatosis, and inflammation in mice by altering the composition and metabolites of gut microbiota.
Food Funct
; 15(8): 4421-4435, 2024 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38563324
17.
The recurrent deep intronic pseudoexon-inducing variant COL6A1 c.930+189C>T results in a consistently severe phenotype of COL6-related dystrophy: Towards clinical trial readiness for splice-modulating therapy.
medRxiv
; 2024 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38585825
18.
Identification of Biallelic dystrophin gene variants during maternal carrier testing for Becker muscular dystrophy and review of the DMD exon 49-51 deletion phenotype.
Mol Genet Genomic Med
; 11(1): e2088, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36424846
19.
Use of supported standing in males with Duchenne muscular dystrophy: Individual and family perspectives.
J Pediatr Rehabil Med
; 16(3): 553-569, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36617765
20.
Pamrevlumab, a Fully Human Monoclonal Antibody Targeting Connective Tissue Growth Factor, for Non-Ambulatory Patients with Duchenne Muscular Dystrophy.
J Neuromuscul Dis
; 10(4): 685-699, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37248912